Benefits of Roux-en-Y Gastric Bypass Sustained in the Long Term

Medically reviewed by Carmen Pope, BPharm. Last updated on June 19, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, June 19, 2024 -- Roux-en-Y gastric bypass (RYGB) is successful in achieving long-term sustained weight loss and diabetes remission, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.

John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylvania, and colleagues examined long-term (>15 year) outcomes for 1,388 patients following RYGB (performed at a single institution from 2001 to 2008). 

Preoperative mean age was 46 years, and body mass index was 47.9 kg/m2. The researchers found maximum mean post-RYGB weight loss (31.8 percent) at 18 months after surgery. At 10 to 20 years post-RYGB, mean weight loss stabilized at 23 percent. There were 677 patients with preoperative diabetes; diabetes remission rates were 54 percent at three years, but decreased to 38 percent at 15 years. Preoperative insulin-treated diabetes was associated with a higher rate of persistent diabetes post-RYGB. Following RYGB, the overall 15-year death rate was 13.3 percent, but reached 37.4 percent in patients with diabetes who were older than 60 years.

"With the availability of medical and endoscopic therapies, the demonstration of long-term effectiveness of gastric bypass that exceeds that of these alternatives is critical to providing the right intervention for the right patient at the right time," coauthor Anthony T. Petrick, M.D., also from the Geisinger Health System, said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords